Infusion time and line compatibility

Vantrexa · Metastatic NSCLC

MI-2026-0623RoutineArchivedWithin SLA

FAFatima Al-SayedMedical Information Lead

Received: 14 Aug 2026, 07:00 UTC
Channel: Email
Requestor type: HCP
Country / region / team: United States · North America · MI Americas
Category: Administration
Response type: Standard response
Owner: FAFatima Al-Sayed
Due: 19 Aug 2026, 07:00 UTC
Responded: 14 Aug 2026, 23:00 UTC
Quality review: Not required
Related insight: —
Related standard response: SR-VTX-011 · Infusion time and line compatibility (v1)

Workflow

12-stage inquiry workflow (PRD §16). Advancing records an audit event.

Current stageArchivedDemo action — not persisted

Routine: 120 h target · Routine 120 h / Urgent 48 h / Critical 24 h

SLA hours

120

Elapsed

16 h

to response

Remaining

104 h

13%

14 Aug 2026, 07:00 UTC
Received via Email
HCP · United States
14 Aug 2026, 07:00 UTC
Triage and assignment
Urgency Routine · assigned to MI Americas
14 Aug 2026, 23:00 UTC
Response sent
Standard response · quality review not required
19 Aug 2026, 07:00 UTC
SLA due (120 h)

Demo — drafts are not persisted

AI suggestion available for non-safety inquiries

Draft response

No audit events for this record

Create, update, approve and export events appear here with user, timestamp, previous and new values.

Data lineage: MI inquiry platform (IRMS, INT-05) · received 14 Aug 2026 · hourly sync.